Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Antibodies
Filter     Order     Display # 
Date Item Title
09 Jan 2007 Cambridge Antibody Technology Licenses Monoclonal Antibody (CAT-213) For Treatment Of Allergy Disorders To iCO Therapeutics
09 Jan 2007 Antibody-Company f-star Raises EUR1.5 Million in Seed Financing Round From Atlas Venture
06 Jan 2007 Helix BioPharma Corp. signs L-DOS47 manufacturing agreement with BioVectra dcl
06 Jan 2007 DSM Biologics and Crucell Announce PER.C6(R) Licensing Agreement with Biotecnol SA for Antibody Production
05 Jan 2007 Elusys Announces Collaborative Research And License Agreement With Pfizer
05 Jan 2007 Medarex Announces Enrollment Complete in Ipilimumab (MDX-010) Monotherapy Pivotal Registrational Trial for Metastatic Melanoma
05 Jan 2007 Raven Biotechnologies, Inc. And Wyeth (WYE) Partner To Evaluate And Develop
05 Jan 2007 Genentech Announces Positive Results from a Randomized Phase II Study of Pertuzumab in Combination with Gemcitabine for Advanced Ovarian Cancer
04 Jan 2007 MacroGenics and JDRF Form Partnership to Support Pivotal Phase II/III Clinical Trial of Anti-CD3 Monoclonal Antibody for Children and Adults With Recent-Onset Type 1 Diabetes
04 Jan 2007 Imclone Systems Commences Patient Treatment in U.S. Phase I Clinical Trial of IMC-3G3
29 Dec 2006 MedImmune In-Licenses Novel Inflammatory Disease Target
28 Dec 2006 Grifols licensed by the FDA to market a new generation of IVIG in the United States
23 Dec 2006 UCB announces positive results from two new phase III studies in rheumatoid arthritis and provides update on the status of US approval for CIMZIA(TM) in the treatment of Crohn's disease
21 Dec 2006 ZymoGenetics and Serono Begin Phase 2 Clinical Trial With Atacicept in Rheumatoid Arthritis
21 Dec 2006 MorphoSys Enlarges Therapeutic Antibody Collaboration with Pfizer - Expansion Doubles Potential Deal Volume for MorphoSys
21 Dec 2006 Seattle Genetics Initiates Phase II Clinical Trial of SGN-40 for the Treatment of Non-Hodgkin's Lymphoma
20 Dec 2006 Glaxosmithkline And Genmab Enter Global Agreement For HuMax-CD20
20 Dec 2006 MedImmune Strengthens Inflammatory Disease Pipeline Through Collaboration With Biowa
19 Dec 2006 Phase II/III pivotal study with trifunctional antibody removab® shows encouraging results in malignant ascites
16 Dec 2006 Elan and Biogen Idec Submit Supplemental Biologics License Application to the FDA for the Approval of TYSABRI(R) as a Treatment for Crohn's Disease
16 Dec 2006 ImmunoGen, Inc. Announces Presentation of First Clinical Data for Genentech's Trastuzumab-MCC-DM1
16 Dec 2006 Genmab Announces AMG 714 Development Update
16 Dec 2006 Bradmer Meets with FDA on Initiation of Phase III Trial for Neuradiab
15 Dec 2006 Peregrine Pharmaceuticals and Biotecnol to Collaborate on Development of Immunocytokine Fusion Proteins for Cancer and Anti-Viral Indications
15 Dec 2006 Progenics Achieves Enrollment Target in Clinical Trial of HIV Entry Inhibitor PRO 140
15 Dec 2006 Key Herceptin Data Presented at San Antonio Breast Cancer Symposium
14 Dec 2006 Crucell Announces Start of Rabies Antibody Product Clinical Trial
14 Dec 2006 New England Journal of Medicine Publishes Data From Pivotal Study of Avastin Plus Chemotherapy in Most Common Type of Lung Cancer
13 Dec 2006 ZymoGenetics Presents Results From Two Atacicept Phase 1b Clinical Trials in B-Cell Cancer
13 Dec 2006 Genmab Announces HuMax-ZP3 Cancer Program
13 Dec 2006 Active Biotech’s Novel Cancer Treatment ANYARA Shows Pharmacological Proof of Concept after Successful Phase I Studies
12 Dec 2006 Interim Analysis of Phase III Trial Shows Avastin Plus Interferon Therapy Improved Progression-Free Survival in Patients With Previously Untreated Advanced Renal Cell Carcinoma
12 Dec 2006 PDL BioPharma Presents Preclinical Data on Novel Monoclonal Antibody for Multiple Myeloma at the American Society of Hematology Annual Meeting
12 Dec 2006 Ipilimumab (MDX-010) Safety and Clinical Response Data in Lymphomas and Leukemia Presented at the 48th American Society of Hematology Annual Meeting
12 Dec 2006 Updated Interim Long-Term Follow-up Data Reported AMG 531 Dosed Once Weekly Increased and Sustained Platelet Counts in Patients with Immune Platelet Disorder
12 Dec 2006 Final Data from Phase III Study Show Single-Agent Alemtuzumab (Campath(R), MabCampath(R)) Superior to Chlorambucil for Patients with Previously Untreated B-CLL
12 Dec 2006 GPC Biotech Presents Preliminary Clinical Data on Anticancer Monoclonal Antibody 1D09C3 at ASH
12 Dec 2006 Genmab Initiates Humax-CD20 Front Line CLL Study
12 Dec 2006 Seattle Genetics Reports Positive Phase I Clinical Trial Results with SGN-40 in Non-Hodgkin's Lymphoma and Multiple Myeloma at ASH
12 Dec 2006 ImmunoGen, Inc. Announces Presentation at ASH of Encouraging Findings with HuN901-DM1 for the Treatment of Multiple Myeloma
12 Dec 2006 Micromet Announces Interim Phase 1 Data of MT103 at the 48th Annual Meeting of the American Society of Hematology (ASH)
12 Dec 2006 XOMA Announces Pre-Clinical and Clinical Progress On HCD122
12 Dec 2006 Symphogen and Meiji enter agreement
11 Dec 2006 Genmab Announces Early Results Of Ongoing Humax-CD4 Trials
11 Dec 2006 Phase I/II Data Support Continued Development Of Biogen Idec's Novel Anti-CD23 Antibody For Chronic Lymphocytic Leukemia
10 Dec 2006 Eculizumab is Well Tolerated and Demonstrates Significant Improvement During 52 Weeks of Treatment in Open-Label Phase III SHEPHERD Study in PNH Patients
08 Dec 2006 PanGenetics B.V. licenses therapeutic antibody for treatment of pain from Lay Line Genomics S.p.A.
08 Dec 2006 Medarex Announces FDA Fast Track Designations for Ipilimumab for the Treatment of Metastatic Melanoma; Fast Track Designations for First-Line Use in Combination With Chemotherapy and Second-Line Use as Monotherapy
08 Dec 2006 Genentech and AC Immune: Exclusive License Agreement
08 Dec 2006 Eli Lilly and Company Submits New Drug Application for EVISTA for Reduction of Invasive Breast Cancer Risk in Postmenopausal Women
 
<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>
Results 751 - 800 of 1155

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics